Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) EPS (Basic) (2020 - 2025)

Treace Medical Concepts' EPS (Basic) history spans 6 years, with the latest figure at -$0.14 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 1300.0% year-over-year to -$0.14; the TTM value through Dec 2025 reached -$0.93, down 3.33%, while the annual FY2025 figure was -$0.93, 3.33% down from the prior year.
  • EPS (Basic) reached -$0.14 in Q4 2025 per TMCI's latest filing, up from -$0.26 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.01 in Q4 2024 to a low of -$0.34 in Q2 2024.
  • Average EPS (Basic) over 5 years is -$0.19, with a median of -$0.21 recorded in 2022.
  • Peak YoY movement for EPS (Basic): surged 90.0% in 2024, then plummeted 1300.0% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.13 in 2021, then skyrocketed by 46.15% to -$0.07 in 2022, then crashed by 42.86% to -$0.1 in 2023, then soared by 90.0% to -$0.01 in 2024, then tumbled by 1300.0% to -$0.14 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's EPS (Basic) are -$0.14 (Q4 2025), -$0.26 (Q3 2025), and -$0.28 (Q2 2025).